Press release
Ankylosing Spondylitis Global Market Rising Trends, Industry Size, Share Report, Growing Demand and Business Opportunities And Forecast 2024-2033
Ankylosing Spondylitis Global Market
The Business Research Company offers in-depth market insights through Ankylosing Spondylitis Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The ankylosing spondylitis market size has grown strongly in recent years. It will grow from $5.41 billion in 2023 to $5.86 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to hla-b27 discovery, biologic treatments development, pain management approaches, patient advocacy and awareness, nsaids and disease modifying drugs.
The ankylosing spondylitis market size is expected to see strong growth in the next few years. It will grow to $7.89 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to personalized medicine approach, novel biologics development, early intervention and screening, lifestyle and diet management, telemedicine and remote monitoring. Major trends in the forecast period include biosimilar availability, targeted pain therapies, patient-reported outcomes (pros) emphasis, community support programs, regenerative medicine exploration.
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=11962&type=smp
Market Segmentation:
The ankylosing spondylitis market covered in this report is segmented -
1) By Treatment Type: Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biological Therapies, Steroids, Physical Therapies, Surgery
2) By Molecule: Biologics, Biosimilar, Small Molecules
3) By Route of Administration: Parenteral, Oral, Other Routes
4) By Application: Juveniles, Adults
5) By End User: Hospitals, Clinics, Research Laboratories, Other End Users
Major Driver - Ankylosing Spondylitis Market Surges With The Growing Geriatric Population Worldwide
The increasing geriatric population is expected to propel the growth of the ankylosing spondylitis market going forward. The geriatric population refers to an increase in the proportion of elderly people due to changes in the age structure of a population. This demographic shift has increased the number and proportion of people over the age of 60. Ankylosing spondylitis treatment and drugs help to improve mobility and manage pain in the geriatric population having ankylosing spondylitis condition. For instance, in October 2022, according to World Health Organization, a Switzerland-based international public health organization, by 2030, 1 out of 6 people in the world will be aged more than 60 years or above, and in 2020, there was a rise in 1 billion aged people reaching to 1.4 billion. Therefore, the increasing geriatric population is driving the growth of the ankylosing spondylitis market.
Competitive Landscape:
Major companies operating in the ankylosing spondylitis market report are Pfizer Inc., Johnson & Johnson Pvt. Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Amgen Inc., Cedars-Sinai, Viatris Inc., Astellas Pharma Inc., Regeneron Pharmaceuticals Inc., AstraZeneca plc, UCB Inc., Cipla Inc., Zydus Lifesciences Limited, Celltrion Inc., Hetero Labs Ltd., UCSF Health, Janssen Biotech Inc., Sandoz International GmbH, Reliance Life Sciences Pvt. Ltd., Affibody Medical AB
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/ankylosing-spondylitis-global-market-report
Top Trend - Advancements In Therapeutic Options Drive Growth In The Ankylosing Spondylitis Market
The advancements in therapeutic options are a key trend gaining popularity in the ankylosing spondylitis market. Companies operating in ankylosing spondylitis are advancing new therapeutic options to sustain their position in the market. For instance, in December 2021, Pfizer Inc., a US-based pharmaceutical and biotechnology company received FDA approval for XELJANZ (tofacitinib) for the treatment of active ankylosing spondylitis. XELJANZ (tofacitinib) is a Janus kinase (JAK) inhibitor effective for five immuno-inflammatory conditions. This medication is effective against intolerance or inadequate response to one or more tumor necrosis factor (TNF) blockers. The XELJANZ (tofacitinib) does not require infusion or injection to deliver the medication.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Ankylosing Spondylitis Market Characteristics
3. Ankylosing Spondylitis Market Trends And Strategies
4. Ankylosing Spondylitis Market - Macro Economic Scenario
5. Ankylosing Spondylitis Market Size And Growth
…..
27. Ankylosing Spondylitis Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ankylosing Spondylitis Global Market Rising Trends, Industry Size, Share Report, Growing Demand and Business Opportunities And Forecast 2024-2033 here
News-ID: 3426359 • Views: …
More Releases from The Business research company
Emerging Sub-Segments Transforming the Cold Pressed Juice Market Landscape
The cold pressed juice market is on the verge of significant expansion as consumers increasingly seek healthier and more functional beverage options. Shifting preferences towards immunity-boosting drinks and sustainability are driving innovation and growth in this sector. Let's explore the current market size, influential players, emerging trends, and segment breakdowns shaping the future of cold pressed juices.
Cold Pressed Juice Market Size and Growth Expectations Through 2030
The market for…
Top Companies and Industry Competition in the Coffee Franchise Market
The coffee franchise industry is positioned for significant expansion in the coming years, driven by evolving consumer preferences and strategic market initiatives. Increasing demand for high-quality coffee experiences and innovative business models is shaping the future landscape. Let's explore the current market size, leading companies, key trends, and major segments that define this dynamic sector.
Projected Growth and Market Size of the Coffee Franchise Market by 2030
The coffee franchise…
Coconut Sugar Market Overview: Major Segments, Strategic Developments, and Leadi …
The coconut sugar market is gaining significant momentum and is poised for notable expansion over the coming years. Driven by evolving consumer preferences and increasing interest in healthier and sustainable sweeteners, this market presents promising opportunities for businesses and consumers alike. Let's explore the market's size, key players, emerging trends, and segmentation in detail.
Projected Expansion of the Coconut Sugar Market Size Through 2030
The coconut sugar market is forecasted…
Emerging Sub-Segments Transforming the Clarithromycin Tablets Market Landscape
The clarithromycin tablets market is poised for notable expansion in the coming years, driven by several healthcare and pharmaceutical developments. As demand for effective antibiotic treatments rises globally, this sector is attracting considerable attention from manufacturers and healthcare providers alike. Let's explore the market's size, key players, prevailing trends, and segmentation to understand its current landscape and future potential.
Projected Market Valuation and Growth Trajectory for Clarithromycin Tablets
The clarithromycin…
More Releases for Ankylosing
Ankylosing Spondylitis Market Treatment Advances and Global Growth Forecast
The Ankylosing Spondylitis (AS) Market focuses on therapies, diagnostics, and devices used for managing ankylosing spondylitis, a chronic inflammatory disease primarily affecting the spine and sacroiliac joints. AS is characterized by pain, stiffness, and progressive spinal fusion, which can significantly impact patient quality of life. Market offerings include biologic therapies, non-steroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), physiotherapy tools, and diagnostic imaging solutions.
Download Full PDF Sample Copy of Market…
Ankylosing Spondylitis Market Trends That Will Shape the Next Decade: Insights f …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Ankylosing Spondylitis Market Size By 2025?
The valuation of the ankylosing spondylitis sector has experienced robust expansion over the past few years, projected to advance from a figure of $5.9 billion in the year 2024 up to $6.34 billion by 2025, reflecting a compound annual…
Ankylosing Spondylitis Market Surges With The Growing Geriatric Population World …
The Ankylosing Spondylitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Ankylosing Spondylitis Market Size and Its Estimated Growth Rate?
The Ankylosing Spondylitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034.…
Ankylosing Spondylitis Uncovered: Market Dynamics and Future Projections
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/request-sample/2638
Introduction:
The global ankylosing spondylitis market has been on a steady rise, reflecting the growing awareness and prevalence of this inflammatory condition. With a remarkable market size of $5,140.94 million in 2020, the projections indicate a substantial leap to $8,110.59 million by 2030. Ankylosing spondylitis, often misunderstood, is a complex disorder that affects the spine's flexibility and posture, potentially leading to severe complications if not managed effectively.
Unveiling Ankylosing…
Ankylosing Spondylitis Market Overview With Detailed Analysis 2022-2028
According to Precision Business Insights (PBI), the latest report, ankylosing spondylitis market is expected to be valued at USD 5,460.5 million in 2022 which is expected to grow at a CAGR of 4.8% over 2022-2028. The primary factors that drive the market are the presence of biosimilars, usage of novel products, and increasing prevalence of ankylosing spondylitis.
View the detailed report description here - https://precisionbusinessinsights.com/market-reports/ankylosing-spondylitis-market/
Retail Pharmacy to Dominate the…
Ankylosing Spondylitis Market Challenges and Investment Opportunities by 2027
Allied Market Research published a report, titled, “Ankylosing Spondylitis Market: Global Opportunity Analysis and Industry Forecast 2020–2027.” According to the report, the global Ankylosing Spondylitis industry garnered $XX billion in 2019, and is expected to generate $xx billion by 2027, witnessing a CAGR of xx% from 2020 to 2027.
Click Here To Access Sample Report https://www.alliedmarketresearch.com/request-sample/10631
Major players analyzed include AbbVie Inc., Janssen Pharmaceuticals Inc., Pfizer Inc., Sandoz International GmbH, Amgen…
